M1 Kliniken AG decides to buy back shares

Publication of inside information pursuant to Art. 17 of Regulation (EU) No. 596/2014

Berlin, 20.04.2023 - The Management Board of M1 Kliniken AG today resolved to repurchase up to 1,500,000 shares of the Company in a total volume not exceeding EUR 10,800,000.00 (excluding incidental acquisition costs). The resolution is based on the authorisation of the Annual General Meeting of 9 July 2020 to acquire own shares. The buyback programme is to start on 28 April 2023 and be completed by the end of 26 April 2024 at the latest. The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company. The sole purpose of the share buyback programme is to use the repurchased shares for all purposes provided for in the authorisation resolution of the Company's Annual General Meeting of 9 July 2020 and for all other purposes permitted under the law governing the Company's shares.

The buy-back programme and its implementation shall take place in compliance with the requirements of the safe harbour regulations pursuant to Art. 5 para. 2 of the Market Abuse Regulation (EU) No. 596/2014 and Art. 2, 3 and 4 of the Delegated Regulation (EU) No. 2016/1052, with the exception of the purpose of the buy-back. This is broader than determined by Art. 5 para. 2 of the Market Abuse Regulation.

Berlin, 05.05.2023 - In the period from 20.04.2023 up to and including 04.05.2023, M1 Kliniken AG has acquired 7.299 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 Acombined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.

Shares were purchased as follows:

Date

Number of shares

Average price (EUR)

28.04.2023

1.895

7,9644

02.05.2023

800

7,96

03.05.2023

737

7,8363

04.05.2023

1.897

7,96

05.05.2023

1.970

7,56

Total

7.299

 

 

The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.

Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).

 

Berlin, 12.05.2023 - In the period from 08.05.2023 up to and including 12.05.2023, M1 Kliniken AG has acquired 10.393 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.

Shares were purchased as follows:

Date

Number of shares

Average price (EUR)

08.05.2023

2.042

7,6

09.05.2023

2.089

7,7

10.05.2023

2.115

7,64

11.05.2023

2.069

7,65

12.05.2023

2,078

7,69

Total

10.393

 

 

The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.

Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).

 

Berlin, 19.05.2023 - In the period from 15.05.2023 up to and including 19.05.2023, M1 Kliniken AG has acquired 8.835 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.

Shares were purchased as follows:

Date

Number of shares

Average price (EUR)

15.05.2023

2.206

7,8

16.05.2023

2.193

7,76

17.05.2023

2.267

7,9

18.05.2023

2.169

7,92

19.05.2023

-

-

Total

8.835

 

 

The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 19.05.2023 amounts to 26.527.

The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.

Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).

 

Berlin, 26.05.2023 - In the period from 22.05.2023 up to and including 26.05.2023, M1 Kliniken AG has acquired 5.992 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.

Shares were purchased as follows:

Date

Number of shares

Average price (EUR)

22.05.2023

1.131

7,79

23.05.2023

1.062

7,7

24.05.2023

1.081

7,54

25.05.2023

1.268

7,67

26.05.2023

1.450

7,76

Total

5.992

 

 

The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 26.05.2023 amounts to 32.519.

The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.

Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).

Berlin, 02.06.2023 - In the period from 29.05.2023 up to and including 02.06.2023, M1 Kliniken AG has acquired 8.157 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.

Shares were purchased as follows:

Date

Number of shares

Average price (EUR)

29.05.2023

880

8

30.05.2023

1.686

8,1

31.05.2023

1.692

8,01

01.06.2023

1.931

8,69

02.06.2023

1.968

8,56

Total

8.157

 

 

The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 02.06.2023 amounts to 40.676.

The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.

Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).

Berlin, 09.06.2023 - In the period from 05.06.2023 up to and including 09.06.2023, M1 Kliniken AG has acquired 7.316 shares in the context of its ongoing share buyback programme, which was published by notice dated 20.04.2023 pursuant to Art. 5 (1) lit. a) Regulation (EU) No. 596/2014 combined with Art. 2 paragraph 1 of Delegated Regulation (EU) No. 2016/1052.

Shares were purchased as follows:

Date

Number of shares

Average price (EUR)

05.06.2023

1.975

8,26

06.06.2023

1.991

7,98

07.06.2023

1.971

7,9

08.06.2023

0

0

09.06.2023

1.379

7,98

Total

7.316

 

 

The total number of shares purchased in the context of the share buy-back program since 20.04.2023 through, and including, 09.06.2023 amounts to 47.992.

The share buyback and the purchase settlement will be carried out exclusively by a credit institution or an investment firm, which will decide on the timing of the acquisition of shares independently of and without influence by the Company.

Detailed transaction information pursuant to Art. 2 (3) Delegated Regulation(EU) No 2016/1052 can be found on the website of M1 Kliniken AG (https://www.m1-kliniken.de/).